BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6293886)

  • 1. Gonadal function in men with testis cancer.
    Berthelsen JG; Skakkebaek NE
    Fertil Steril; 1983 Jan; 39(1):68-75. PubMed ID: 6293886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
    Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
    J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired testicular function in patients with carcinoma-in-situ of the testis.
    Petersen PM; Giwercman A; Hansen SW; Berthelsen JG; Daugaard G; Rørth M; Skakkebaek NE
    J Clin Oncol; 1999 Jan; 17(1):173-9. PubMed ID: 10458231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ cell function and hormonal status in patients with testicular cancer.
    Hansen PV; Trykker H; Andersen J; Helkjaer PE
    Cancer; 1989 Aug; 64(4):956-61. PubMed ID: 2545331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.
    Carroll PR; Whitmore WF; Herr HW; Morse MJ; Sogani PC; Bajorunas D; Fair WR; Chaganti RS
    J Urol; 1987 Mar; 137(3):420-3. PubMed ID: 3029434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadal function and fertility in patients with bilateral testicular germ cell malignancy.
    Jacobsen KD; Fosså SD; Bjøro TP; Aass N; Heilo A; Stenwig AE
    Eur Urol; 2002 Sep; 42(3):229-38; discussion 237-8. PubMed ID: 12234507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadal function after multimodality treatment in men with testicular germ cell cancer.
    Palmieri G; Lotrecchiano G; Ricci G; Spiezia R; Lombardi G; Bianco AR; Torino G
    Eur J Endocrinol; 1996 Apr; 134(4):431-6. PubMed ID: 8640293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human chorionic gonadotropin beta-subunit in human semen.
    Saito S; Kumamoto Y; Ito N; Kurohata T
    Arch Androl; 1988; 20(1):87-99. PubMed ID: 2455489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility and hormonal function in patients with a nonseminomatous tumor of the testis.
    Nijman JM; Schraffordt Koops H; Kremer J; Willemse PH; Sleijfer DT; Oldhoff J
    Arch Androl; 1985; 14(2-3):239-46. PubMed ID: 2415075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sperm integrity pre- and post-chemotherapy in men with testicular germ cell cancer.
    Spermon JR; Ramos L; Wetzels AM; Sweep CG; Braat DD; Kiemeney LA; Witjes JA
    Hum Reprod; 2006 Jul; 21(7):1781-6. PubMed ID: 16601009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
    J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy.
    Berthelsen JG; Engelholm SA; von der Maase H; Rørth M
    Scand J Urol Nephrol; 1983; 17(3):287-90. PubMed ID: 6316483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteinizing hormone regulation by sex steroids in men with germinal and Leydig cell tumours.
    Reznik Y; Rieu M; Kuhn JM; Mandard JC; Bottet P; Lemonnier D; Bekka S; Mahoudeau J
    Clin Endocrinol (Oxf); 1993 May; 38(5):487-93. PubMed ID: 8392454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
    Van Thiel DH; Sherins RJ; Myers GH; De Vita VT
    J Clin Invest; 1972 Apr; 51(4):1009-19. PubMed ID: 4552337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients.
    Giwercman A; von der Maase H; Berthelsen JG; Rørth M; Bertelsen A; Skakkebaek NE
    J Clin Endocrinol Metab; 1991 Sep; 73(3):596-603. PubMed ID: 1908483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment follicle-stimulating hormone: a prognostic serum marker of spermatogenesis status in patients treated for germ cell cancer.
    Brennemann W; Stoffel-Wagner B; Wichers M; Helmers A; Albers P; Mezger J; Klingmüller D
    J Urol; 1998 Jun; 159(6):1942-6. PubMed ID: 9598493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect.
    Willemse PH; Sleijfer DT; Sluiter WJ; Schraffordt Koops H; Doorenbos H
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):616-24. PubMed ID: 6133401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lowered reference limits for hCG improve follow-up of patients with hCG-producing tumors.
    Nome RV; Bjøro T; Paus E; Bjerner J; Fosså SD; Steen R; Nustad K; Bolstad N
    Clin Biochem; 2018 Feb; 52():73-79. PubMed ID: 29198759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadal dysfunction in patients treated for metastatic germ-cell tumors.
    Leitner SP; Bosl GJ; Bajorunas D
    J Clin Oncol; 1986 Oct; 4(10):1500-5. PubMed ID: 3020183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis.
    Bay K; Hartung S; Ivell R; Schumacher M; Jürgensen D; Jorgensen N; Holm M; Skakkebaek NE; Andersson AM
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3410-8. PubMed ID: 15755855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.